RSS

Macrilen

Aeterna Zentaris has selected Ergomed to manage the confirmatory Phase 3 clinical study demonstrating the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency. more

News